Related Experiment Video
Updated: Jul 8, 2026
10:03
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Current trends in type 1 diabetes mellitus--stem cells and beyond
Mozaffer Rahim Hingorjo1, Sadiqa Syed, Masood A Qureshi
1Department of Physiology, Fatima Jinnah Dental College.
JPMA. the Journal of the Pakistan Medical Association
|January 5, 2008
Summary
Researchers are exploring stem cells, particularly embryonic stem cells, as a promising avenue for a type-1 diabetes mellitus cure. This approach aims to generate sufficient beta cells for transplantation and overcome immune destruction.
Area of Science:
- Immunology
- Endocrinology
- Regenerative Medicine
Background:
- Type-1 diabetes mellitus (T1DM) results from autoimmune destruction of insulin-producing beta cells.
- Current research focuses on beta cell replacement and preventing immune attack.
- Islet transplantation shows promise but faces limitations in beta cell acquisition.
Purpose of the Study:
- To review current research directions for T1DM.
- To discuss the progress of stem cell technology in T1DM treatment.
- To highlight the potential of embryonic stem cells for beta cell regeneration.
Main Methods:
- Review of current scientific literature on T1DM research and stem cell applications.
- Analysis of advancements in immunosuppressive therapies, including monoclonal antibodies.
- Evaluation of embryonic stem cell properties for differentiation and proliferation.
Main Results:
- Embryonic stem cells offer potential for unlimited proliferation and differentiation into various cell types.
- Improved immunosuppressive protocols enhance the viability of transplanted cells.
- Stem cell technology presents a viable strategy to overcome the scarcity of beta cells for transplantation.
Conclusions:
- Stem cell-based therapies, especially using embryonic stem cells, are a promising strategy for a T1DM cure.
- Further research is needed to optimize stem cell differentiation and transplantation protocols.
- Advancements in immunosuppression complement stem cell approaches for T1DM treatment.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...